Share this article
Share this article
CHICAGO, May 25, 2021 /PRNewswire/ In-depth analysis and data-driven insights on the impact of COVID-19 included in this global regenerative medicine market report.
The regenerative medicine market is expected to grow at a CAGR of over 30% during the period 2020−2026.
Key Highlights Offered in the Report:
The percentage share of gene therapy in the global market is more than 40% in 2020, which is expected to double by the year 2026.
As CAR-T therapy is widely popular these days for the treatment of chronic cancers, the key vendors in the market are increasing their focus on developing the products in CAR-T cell therapy. In February 2021 US FDA approved Breyanzi, a CAR-T cell therapy product to treat adults with relapsed or refractory large B-cell lymphoma.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Over the past few years, the idea of immunotherapy of ability to manipulate immune cells in targeting tumor cells is gaining momentum in field of cancer therapeutics. Since then scientists have developed a wide range of potential candidates which has shown encouraging results in the management of cancer.
The recent clinical success of chimeric antigen receptor in the management of hematological malignancies has clearly led to the explosion in the field of adoptive cell therapy for cancer. Researchers are currently putting efforts for the translation of this exciting technology in solid tumors and the development of allogeneic off the shelf therapies.
G2 Bio Companies Launch with US$200 Million to Develop Transformative Genetic-Based Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Takeda Pharmaceuticals
“While we’ve partnered with companies for years to help them offset their flight emissions, we applaud those participating in the Eco-Skies Alliance for recognizing the need to go beyond carbon offsets and support SAF-powered flying, which will lead to more affordable supply and ultimately, lower emissions,” said United CEO Scott Kirby. “This is just the beginning. Our goal is to add more companies to the Eco-Skies Alliance program, purchase more SAF and work across industries to find other innovative paths towards decarbonization.”
United has made the airline industry’s single largest investment in SAF and has purchased more SAF than any other airline in the world. World Energy, a long-term partner of United, will supply the SAF to Los Angeles International Airport (LAX), which makes it conveniently accessible to United’s operations.